theMednetRegister
Journal of the American College of Cardiology 2020 Nov 26
2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee.   

Related Questions

What are your thoughts on the results from the AQUATIC trial which showed that the addition of aspirin daily + oral anticoagulation in patients > 6 months from PCI and with high atherothrombotic risk was associated with a higher risk of death, MI, stroke, coronary revascularization and acute limb ischemia, compared to oral anticoagulation alone?
New answer by at Lahey Hospital & Medical Center, Burlington (October 30, 2025)
I think AQUATIC is a well-designed definitive trial. It shows that in patients with chronic CAD (at least 6 mo. out from stent) who are also receiving anticoagulation (typical...
Copyright © 2025 theMednet
All Rights Reserved.